TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (“ Aleafia” or the “ Corporation ”) announces that Red White & Bloom Brands Inc. (“ RWB ”) has been selected as the successful bidder pursuant to the Court-approved sale and investment solicitation process (the “ SISP ”) in connection with the previously announced proceedings of Aleafia and certain of its subsidiaries under the Companies’ Creditors Arrangement... Read More

TORONTO, July 25, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“ Aleafia” or the “ Corporation ”) announces today that the Corporation and certain of its Canadian subsidiaries, Emblem Corp., Emblem Cannabis Corporation, Emblem Realty Ltd., Growwise Health Limited, Canabo Medical Corporation, Aleafia Inc., Aleafia Farms Inc., Aleafia Brands Inc., Aleafia Retail Inc., 2672533 Ontario Inc., and 2676063... Read More

TORONTO, July 14, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“ RWB ” or the “ Company ”) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) (“ Aleafia ”) are announcing the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 (the “ Letter Agreement ”) in respect of the proposed business combination transaction (the “ Proposed Transaction... Read More

TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) announces that it is electing to pay interest in-kind on its (a) 8.50% Series A Secured Debentures Due June 30, 2024 (the “ Series A Debentures ”), (b) 8.50% Series B Secured Debentures Due June 30, 2026 (the “ Series B Debentures ”), and (c) 8.50% Series C Secured Convertible Debentures Due June 30,... Read More

Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022 Revenue increased 24% to $57.4 million for the 12 months ended March 31, 2023 (“FY2023”) over the twelve months ended March 31, 2022 Net revenue increased 19% to $42.8... Read More

The Combined Company (as defined below) is expected to represent C$138 million in trailing distribution and retail revenue from the Canadian, United States and European cannabis end-markets and combined Gross Profit before fair value adjustments of $39 million. (1)(2)(3)(4) On a combined basis, RWB and Aleafia are expected to service approximately 3,000 retail locations in North America. Expected annualized synergies of... Read More

TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) announces that the Company has entered into a forbearance agreement with NE SPC II LP (“NE SPC”) extending the forbearance period under its loan agreement with NE SPC until June 5, 2023. The forbearance agreement comes in light of ongoing negotiations between the Company, NE SPC and a potential... Read More

TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) announces that the Company has entered into an amendment to the terms of the loan agreement with NE SPC II LP (“ NE SPC ”) dated as of December 24, 2021 and as previously amended by agreements dated March 28, 2022 and June 17, 2022 (the “ Loan Agreement ”). While the original Loan Agreement provided... Read More

2nd consecutive quarter of positive Adjusted EBITDA 1 4% Adjusted EBITDA margin 2 places company in top 3 position for profitability amongst its peers 3 9% growth in adult use revenue 4 over prior quarter; 5% growth in adult-use revenue 5 year over year 40% increase in medical net revenue 6 with $1.1 million record month revenue in November 2022 1st shipment made toward new European agreement announced in Q2 FY2023 Estimated... Read More

TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce on February 8 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL &... Read More

TORONTO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc . (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has signed a new European cannabis distribution partner, representing a one-year, approximately $1 million contract 1 , significantly bolstering the Company’s record $1.2 million year-to-date sales in its growing international channel. “This new announcement is very... Read More

Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use products TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has completed the TSX delisting review and confirms that the Company... Read More

Adjusted EBITDA 1 profitability achieved in Q2 FY2023, ahead of plan 21% increase in total revenue year over year to $14.5 23% increase in branded cannabis net revenue 2 year over year to $9.4 million #3 ranking in total retail sales pull through growth among 20 top Canadian LPs 3 #2 milled and #4 pre-roll market share ranking in key Ontario market for Divvy 4 Record quarter in international net revenue 5 16 % increase in... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce on November 9 prior to market open its fiscal year 2023 second quarter results for the period ending September 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : November 9, 2022 Time :... Read More

16 total new listings added to the Sunday Market portfolio by February 2023 9 new Divvy products in profitable flower, vape, and milled categories Kin Slips portfolio expands to include the California brand’s best-selling CBN product Shut Eye Plus CBD-forward brand Noon & Night extends giftable CBD product lineup Innovative Bogart’s Kitchen portfolio adds to condiment offering with classic Canadian pantry staple Aleafia... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the results of the vote on the election of directors at its annual meeting of shareholders held on September 27, 2022 (the “Meeting”). All six nominees set out in the management information circular of the Company dated August 19, 2022 were elected to the board of directors (the “Board”) of the Company. Nominee For Against... Read More

Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) announces that the Toronto Stock Exchange (“ TSX ”) issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted. For Investor & Media Relations: Matthew Sale, CFO 1-833-879-2533 IR@AleafiaHealth.com LEARN MORE:... Read More

31% increase in branded cannabis net revenue 1 to $10.0 million from $7.6 million in the prior year #12 ranking for market share in core markets 2 for Q1 FY2023 In the Ontario value category, Divvy has attained #5 market share in pre-roll and #7 in flower Secured new international partnership representing approximately $4.6 million sales commitment 12% increase in medical cannabis net revenue 3 over the prior quarter 7.5%... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce on August 11 prior to market open its fiscal year 2023 first quarter results for the period ending June 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : August 11, 2022 Time : 8:30 a.m.... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has closed its previously announced amendment of its unsecured convertible debentures (the “ Debenture Amendments ”). “We are delighted we have now completed this transaction,” said Tricia Symmes Aleafia Health’s CEO. “We want to thank all those who participated for demonstrating their confidence in the... Read More

151% increase in branded cannabis net revenue 1 to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million in the prior 12-month year $8 million in branded cannabis net revenue for Q5, a growth of 55% calendar year over calendar year 3rd highest increase in overall market share rankings over the course of the fiscal year among top 20 Canadian LPs 2 168% increase in... Read More

Aleafia Health Inc . (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce on June 28, 2022, prior to market open, its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : June 28, 2022 Time : 8:30... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has closed its previously announced private placement (the “ Private Placement ”) representing aggregate gross proceeds of approximately $5.6 million. Pursuant to the Private Placement, an aggregate of 68,151,515 units were issued at a price of $0.0825 per unit, with each unit consisting of one common share in... Read More

Following final tabulation, Debentureholders pass Extraordinary Resolution approving Debenture Amendments Canceling Debentureholder meeting previously scheduled for June 23, 2022 Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June... Read More

Debentureholders have executed sufficient consents and proxies to approve Debenture Amendments Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “ Debentures ”). Debentureholders representing approximately 73% of the... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce on June 23 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : June 23, 2022 Time : 8:30 a.m. EST... Read More

Debentureholders representing approximately 61.4% of the Convertible Debentures outstanding have entered into Support Agreements 1 , including each member of the Steering Committee nominated by Debentureholders Company more than 90% towards achieving a minimum of 66 2/3% required to pass the Debenture Amendments Debentureholders of record as of May 24, 2022 who provide valid consent and voting instructions in favour of the... Read More

Adult-use cannabis market share increased three positions to 13 th in April 2022 vs 16 th in December 2021 ( 1 ) 53% increase in adult-use market share to 2.5% in April 2022 vs December 2021 ( 2 ) , representing the 5th highest growth rate among the top 40 Canadian LPs Spring & Summer launch of 12 OCS and 8 AGLC SKUs builds depth in key flower, pre-roll and vape product format categories and positions the Company for a... Read More

Transforms the company’s balance sheet with an equity financing to fund growth and a favourable resolution to amend the key commercial terms of the Convertible Debentures Provides $11.6 million 1 in additional liquidity to fund working capital and growth initiatives and finance the company attaining break-even Adjusted EBITDA profitability in 2022 2 Augments the refinancing profile extending the maturity of the Convertible... Read More

Holders representing approximately 62% of total Debentures extend Forbearance Period until May 12, 2022 to allow negotiations to continue Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “ Convertible Debt ”).... Read More

$4.4 million annualized cost reductions being implemented in addition to $2.3 million announced in February 2022 Grimsby, Ontario cultivation organization realigned to support anticipated growth in product throughput Organizational realignment in the medical business to fully integrate the sales channels Core corporate shared services consolidated and leveraged across all sales channels Company operating leverage in the top... Read More

Holders representing approximately 62% of total Debentures extend Forbearance Period until April 11, 2022 to allow negotiations to continue Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “ Convertible Debt ”).... Read More

Reached new record market share overall adult use market share of 2.06% in February 2022, advancing 33% from 1.54% in November 2021 (1) Continued ascent in overall market share rankings, up two more notches to 13th in February 2022 from 15th in November 2021 On the pathway towards a top 10 market share position by the end of 2022 Received first $1 million purchase order Secured seven new listings in Ontario and six in... Read More

Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “ Convertible Debt ”). Further to the Company’s announcement on February 1, 2022, the Forbearance Agreement, entered into between the Company and holders of... Read More

Transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 2020 96% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020 396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in 2020 60% increase in branded cannabis net revenue to $8.3 million in Q4 2021 from $5.2 million... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce results from its three and 12-month periods ending December 31, 2021 on February 14, 2022. The Company will also host its earnings conference call on February 15 at 9:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : February 15, 2022 Time : 9:30 a.m. ET USA/Canada... Read More

TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) today announced that CEO Geoffrey Benic will leave the Company, effective February 7, 2022. To succeed Benic, the Board named Tricia Symmes, previously the Company’s Chief Commercial Officer (CCO), as the Company’s new CEO. “Geoff joined Aleafia in June 2018 at a turning... Read More

Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “ Convertible Debt ”). The Company has initiated negotiations with debenture holders with a view of amending the Convertible Debt to achieve an outcome that is... Read More

Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibility Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce the closing of a credit facility of up to $19 million (the “ Credit Facility ”). “This financing improves our liquidity and capital structure as the Company’s... Read More

$9.6 million net revenue with an improved sales mix focused on the high-growth adult-use and recurring medical cannabis sales channels 2,044% y/y increase in adult-use cannabis net revenue 31% y/y increase in medical cannabis net revenue Top 10 in national market share in pre-rolls achieved subsequent to the reporting period 1 Top 10 in national adult-use market share in edibles and oils categories 1 Outdoor harvest produced... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce its 2021 third quarter results on November 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : November 11, 2021 Time : 9:30 a.m. ET USA/Canada Toll-Free Participant... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) hosted a second annual adult-use retailer harvest party at its outdoor cultivation facility, with over 300 cannabis store owners, managers, budtenders and industry leaders attending. The two-day conference included retailer tours at the 86 acre outdoor site in Port Perry, Ont. and education sessions featuring the company’s cultivation methods and... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce the appointment of David Pasieka to its board of directors. Mr. Pasieka is a seasoned public company executive and director with extensive board level experience in finance & audit, risk management, and ESG. Mr. Pasieka was a long-standing c-suite executive at Algonquin Power & Utilities, overseeing its growth into a... Read More

Credit Facility provides financial capacity to pursue accretive growth opportunities New debt lender increases financial flexibility with new source of capital Improves liquidity by growing cash and marketable securities balance to $25 million Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”), a leader in cannabis wellness products and services, is pleased to announce the closing of a $10... Read More

Adult-use cannabis net revenue increased 87% compared to the prior quarter Medical cannabis net revenue increased 23% compared to the prior quarter 13 additional product SKUs released across multiple product formats For the first time, medical cannabis product was made available for sale in Germany Commenced onboarding of medical cannabis patients through exclusive partnership with Unifor Maintained strong adjusted gross... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce its 2021 second quarter results on August 12, 2021 prior to market open. The Company will also host its earnings conference call the same day at 9:30 a.m. ET. The call will be hosted by CEO Geoffrey Benic and CFO Matt Sale. CONFERENCE CALL & WEBCAST Date : August 12, 2021 Time : 9:30 a.m. ET USA/Canada Toll-Free Participant... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) a global leader in cannabis wellness products and services, is pleased to announce the appointment of Mark J. Sandler as Chairman of its Board of Directors (the “ Board ”). He is the longest serving member of the Company’s board, which is composed entirely of independent directors, and chairs its Governance Committee. Currently senior partner at... Read More

Nith & Grand tailored to cannabis aficionados with discerning taste, and will feature craft flower and premium concentrates Initial launch features TF Pink Kush Live Resin vape cartridges Strengthened product portfolio contributing to meaningful quarterly sales growth across all sales channels Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its premium... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce the results of the vote on the election of directors at its annual meeting of shareholders held on June 28, 2021 (the “Meeting”). All seven nominees set out in the management information circular of the Company dated May 20, 2021 were elected to the board of... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced the expansion of its cannabis edibles portfolio with the first of its kind of Salted Caramel Pretzel Bites. The new format is now available and sold under the Company’s... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce the appointment of Matt Sale to its executive leadership team as chief financial officer, effective today. Mr. Sale is a proven finance professional who brings over 15 years of progressively more senior leadership roles and accomplishments to Aleafia Health.... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), with great regret announces the passing of Daniel Milliard, a valued member of its Board of Directors. “We are tremendously sad that our dear friend and colleague Daniel Milliard has passed away. It was a privilege to serve with Dan on Aleafia’s board and previously at Emblem, where I witnessed firsthand his integrity, work ethic, and business... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”), today announced that CEO Geoffrey Benic will participate in the Cantor Fitzgerald Canadian LPs Cannabis Forum on June 16. Wednesday, June 16 10:00 a.m. ET Registration Link For Investor & Media Relations Nicholas Bergamini, VP Investor Relations 1-833-TSX-ALEF (879-2533) IR@AleafiaHealth.com www.AleafiaHealth.com About Aleafia Health Aleafia... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced that it has largely completed planting across 86 acres at its outdoor cultivation facility in Port Perry, Ont. The milestone was achieved a month earlier, and on a significantly larger scale, than the 2020 outdoor season, which yielded 31,200 kgs of dried flower, at a... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced the expansion of its trailblazing cannabis wellness brand Noon & Night with the launch of the first of its kind CBD Freshly Minted Roll-on. The peppermint-scented roll-on... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced the continued expansion of its dried flower portfolio with the launch of four new large format offerings under its everyday cannabis brand Divvy. The new products strengthen the existing Divvy portfolio following a successful... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has established an at-the-market equity program (the “ ATM Program ”). The ATM Program allows the Company to issue and sell, at its discretion, up to $30,000,000 of common shares in the capital of the Company (the “ Common Shares ”) to the public from time to time through Cantor Fitzgerald Canada Corporation... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that dried flower grown at its Niagara greenhouse facility has been successfully exported to Germany. Gaining access to Europe’s most mature legal cannabis market is an important breakthrough for Aleafia Health, with fulfilment of successive purchase orders to... Read More

Aleafia Health (TSX: AH) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration About Benzinga Cannabis Capital Conference Benzinga's virtual Cannabis Capital... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) a global leader in cannabis wellness products and services, today announced that Benjamin Ferdinand, chief financial officer, is departing the Company on amicable terms to pursue a new opportunity in the technology sector. He will continue to serve as CFO during a transition period. The Company has initiated a search process for a new chief... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to report its financial results for the three months ended March 31, 2021 (“ Q1 2021 ”). “This quarter saw us achieve important executional breakthroughs as we realized the exponential increase of our cannabis product portfolio. Likewise, as we benefit from greater scale, we are demonstrating substantial improvements in the... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”), a global leader in cannabis wellness products and services, is pleased to announce that CEO Geoffrey Benic will present at Canaccord Genuity’s Global Cannabis Conference on Tuesday, May 11, 2021 at 11:00 a.m. EDT. Participants can access the webcast through this link , with a replay expected to be made available shortly after the conclusion... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that its wholly-owned subsidiaries, Canabo Medical Corporation (“ Canabo ”) and GrowWise Health Limited (“ GrowWise ”), (together the “ Vendors ”) have closed a transaction (the “ Transaction ”) with Myconic Capital Corp. (CSE: MEDI) (“ Myconic ”) whereby the Vendors sold certain of their respective clinic assets to... Read More

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human sensory analysis and palatability trials, evaluating the taste, touch, smell and sight of its growing portfolio of... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce its 2021 first quarter results on May 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EDT. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand. CONFERENCE CALL & WEBCAST Date : May 11, 2021 Time : 8:30 a.m. EDT USA/Canada Toll-Free Participant... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath bombs, both of which are now available in the adult-use market. Noon & Night contributes to the daily wellness routine of both new... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its everyday cannabis brand Divvy, tailored to frequent cannabis consumers who are both price and quality conscious. “Led by our experienced growers, Aleafia Health has developed a long track record of cultivating... Read More

233% increase in Q/Q cannabis net revenue $4.3 million positive adjusted EBITDA in Q4 2020 42% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectively Significant product portfolio expansion with 31 new SKUs launched since October Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to report its financial results for the 2020 fourth quarter (“ Q4 2020 ”) and... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its products are now available to consumers in Saskatchewan. The initial provincial launch includes a broad array of Aleafia Health’s cannabis product portfolio, including sublingual strips, cannabis oils, dried flower, and vape cartridges. The Company's adult-use products are now available in four provinces representing... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has closed its previously announced bought deal offering (the “ Offering ”) for a total issuance of 27,390,000 units of the Company (“ Units ”) at a price per Unit of $0.83 for gross proceeds of $22.7 million, which includes a partial exercise of the over-allotment option. The offering was led by Cantor Fitzgerald... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of THC soft chews under its edibles brand Bogart’s Kitchen. They represent Aleafia Health’s premiere cannabis edible product and the first launch under the Bogart’s Kitchen banner. They have commenced shipping to the adult-use market and are available to patients of the Company's medical cannabis subsidiary Emblem.... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) will announce its 2020 fourth quarter and fiscal year results on March 25, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand. CONFERENCE CALL & WEBCAST Date : March 25, 2021 Time : 8:30 a.m. EST USA/Canada... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has agreed to increase the size of its previously announced “bought deal” offering of units led by Cantor Fitzgerald Canada Corporation as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “ Underwriters ”), pursuant to which the Underwriters have agreed to purchase... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “ Underwriters ”), pursuant to which the Underwriters have agreed to purchase 18,000,000 units of the Company (the “ Units ”), on a “bought deal”... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) today announced its wholly owned subsidiary Emblem Cannabis Corporation has received a Health Canada Processing Licence (the “ Licence ”) for its new Distribution Centre (the “ DC ”). Located minutes from Toronto Pearson International Airport, the DC greatly strengthens the Company’s downstream supply chain, allowing for immediate expansion of... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce the launch of its new Canadian cannabis portfolio Sunday Market TM . Under the Sunday Market family are four new distinct brands, each tailored to a specific consumer segment and featuring its own roster of cannabis products. The four brands will be launched in the adult-use market, with some formats also being made... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) today announced the full repayment in cash of its 8% unsecured convertible debt (the “ Convertible Debt ”), which matured on February 2, 2021. Emblem Corp., which issued the Convertible Debt on February 2, 2018, was acquired by the Company on March 14, 2019. “Our team is excited to see continued cannabis sales growth in 2021, driven by new... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to announce that the board of directors (the “ Board ”) has appointed Lu Galasso and Carlo Sistilli as independent directors to the Board. Mr. Galasso will be appointed to the Strategic Planning Committee and Mr. Sistilli will be appointed to the Audit Committee. “I would like to welcome Lu and Carlo to our Board,” said Acting Chair... Read More

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“ Aleafia Health ” or the “ Company ”) today announced that Rhonda Lawson has resigned as a director of the Company. “I would like to sincerely thank Rhonda for her contributions to Aleafia Health. She will be truly missed,” said Acting Chair Lea Ray. “Her independent thinking and expertise were significant assets to the Company, serving us well in our continued growth over the last... Read More